Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma

被引:62
作者
Wislez, M
Fleury-Feith, J
Rabbe, N
Moreau, J
Cesari, D
Milleron, B
Mayaud, C
Antoine, M
Soler, P
Cadranel, J
机构
[1] Hop Tenon, Serv Pneumol & Reanimat Resp, F-75020 Paris, France
[2] Hop Tenon, Serv Histol & Biol Tumorale, F-75020 Paris, France
[3] Hop Tenon, Serv Anat Pathol, Assistance Publ Hop Paris, F-75020 Paris, France
[4] Univ Paris 06, Lab Biol Cellulaire & Immunopathol Pulm, Unite Format & Rech St Antoine, Paris, France
[5] Univ Paris 07, Unite Inserm 408, Paris, France
关键词
D O I
10.1016/S0002-9440(10)62529-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We evaluated the role of the tumor environment in the regulation of apoptosis of tumor-infiltrating neutrophils, the number of which correlates negatively with outcome, in patients with adenocarcinoma of the bronchioloalveolar (BAC) subtype. We examined three different parameters of apoptosis, namely morphological aspect, annexin-V expression, and DNA fragmentation. Bronchoalveolar lavage fluid (BALF) supernatants from patients with BAC significantly inhibited the 24-hour spontaneous apoptosis of normal peripheral blood neutrophils in vitro compared to BALF supernatants from control patients (64 +/- 4% versus 90 +/- 2% measured by annexin-V flow cytometry, P = 0.04). The alveolar neutrophil count correlated positively with the granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) concentrations in the patient's BALF. Furthermore, neutralizing antibodies (Abs) against GM-CSF and G-CSF significantly inhibited BALF anti-apoptotic activity (15 to 40% and 34 to 63% inhibition, respectively), whereas neutralizing Abs against interleukin (IL)-8, IL-6, IL-1 beta and tumor necrosis factor-alpha had no significant effect. In an attempt to identify the cell origin of anti-apoptotic cytokines, we tested in vitro the effect of BAC cells (A549 cell line and primary culture derived from a patient's BAC tumor) on the apoptosis of peripheral blood neutrophils. Cell-free supernatants from tumor cells did not inhibit neutrophil apoptosis. In contrast, cell-free supernatants from tumor cells previously exposed to conditioned media from peripheral blood mononuclear cells and alveolar macrophages significantly inhibited spontaneous neutrophil apoptosis. This inhibition was partially lifted when conditioned media from mononuclear cells were previously treated with Abs against IL-1 beta and tumor necrosis factor-alpha. As in vivo, neutralizing Abs against GM-CSF significantly inhibited the anti-apoptotic activity of cell culture supernatants, and combination with Abs against G-CSF had an additive effect. In vivo, GM-CSF and G-CSF were strongly expressed by tumor cells and moderately or not expressed by the normal epithelium, as assessed by immunohistochemical studies. These findings demonstrate that the tumor environment generates local conditions that prolong alveolar neutrophil survival through the production of soluble factors, thereby contributing to the persistence of the neutrophil alveolitis observed in BAC.
引用
收藏
页码:1423 / 1433
页数:11
相关论文
共 48 条
[1]  
AUERBACH O, 1991, CANCER, V68, P1973, DOI 10.1002/1097-0142(19911101)68:9<1973::AID-CNCR2820680921>3.0.CO
[2]  
2-Z
[3]  
BARSKY SH, 1994, CANCER-AM CANCER SOC, V73, P1163, DOI 10.1002/1097-0142(19940215)73:4<1163::AID-CNCR2820730407>3.0.CO
[4]  
2-J
[5]  
Bellocq A, 1998, AM J PATHOL, V152, P83
[6]   INTERLEUKIN-6 SUPPRESSION OF NEUTROPHIL APOPTOSIS IS NEUTROPHIL CONCENTRATION-DEPENDENT [J].
BIFFL, WL ;
MOORE, EE ;
MOORE, FA ;
BARNETT, CC .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (05) :582-584
[7]  
BRACH MA, 1992, BLOOD, V80, P2920
[8]  
BRAILLY H, 1993, LEUKEMIA, V7, P1557
[9]   ROLE OF CYTOKINES IN DISTRIBUTION AND DIFFERENTIATION OF DENDRITIC CELL LARGERHANS CELL LINEAGE IN HUMAN PRIMARY CARCINOMAS OF THE LUNG [J].
COLASANTE, A ;
CASTRILLI, G ;
AIELLO, FB ;
BRUNETTI, M ;
MUSIANI, P .
HUMAN PATHOLOGY, 1995, 26 (08) :866-872
[10]  
COLOTTA F, 1992, BLOOD, V80, P2012